These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Real-World Outcomes of Acute Ischemic Stroke Treatment with Intravenous Recombinant Tissue Plasminogen Activator. Betts KA; Hurley D; Song J; Sajeev G; Guo J; Du EX; Paschoalin M; Wu EQ J Stroke Cerebrovasc Dis; 2017 Sep; 26(9):1996-2003. PubMed ID: 28689999 [TBL] [Abstract][Full Text] [Related]
23. Early and continuous neurologic improvements after intravenous thrombolysis are strong predictors of favorable long-term outcomes in acute ischemic stroke. Yeo LL; Paliwal P; Teoh HL; Seet RC; Chan BP; Wakerley B; Liang S; Rathakrishnan R; Chong VF; Ting EY; Sharma VK J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e590-6. PubMed ID: 23954601 [TBL] [Abstract][Full Text] [Related]
24. Outcome of stroke patients receiving different doses of recombinant tissue plasminogen activator. Ong CT; Wong YS; Wu CS; Su YH Drug Des Devel Ther; 2017; 11():1559-1566. PubMed ID: 28572721 [TBL] [Abstract][Full Text] [Related]
25. Effects of admission hyperglycemia on stroke outcome in reperfused tissue plasminogen activator--treated patients. Alvarez-SabĂn J; Molina CA; Montaner J; Arenillas JF; Huertas R; Ribo M; Codina A; Quintana M Stroke; 2003 May; 34(5):1235-41. PubMed ID: 12677014 [TBL] [Abstract][Full Text] [Related]
26. Leukocytosis in patients with neurologic deterioration after acute ischemic stroke is associated with poor outcomes. Kumar AD; Boehme AK; Siegler JE; Gillette M; Albright KC; Martin-Schild S J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):e111-7. PubMed ID: 23031742 [TBL] [Abstract][Full Text] [Related]
28. Impact of neurological and medical complications on 3-month outcomes in acute ischaemic stroke. Hong KS; Kang DW; Koo JS; Yu KH; Han MK; Cho YJ; Park JM; Bae HJ; Lee BC Eur J Neurol; 2008 Dec; 15(12):1324-31. PubMed ID: 19049549 [TBL] [Abstract][Full Text] [Related]
29. Systemic inflammatory response depends on initial stroke severity but is attenuated by successful thrombolysis. Audebert HJ; Rott MM; Eck T; Haberl RL Stroke; 2004 Sep; 35(9):2128-33. PubMed ID: 15272127 [TBL] [Abstract][Full Text] [Related]
35. The role of the complement cascade in ischemia/reperfusion injury: implications for neuroprotection. D'Ambrosio AL; Pinsky DJ; Connolly ES Mol Med; 2001 Jun; 7(6):367-82. PubMed ID: 11474130 [TBL] [Abstract][Full Text] [Related]
36. Stroke severity determines body temperature in acute stroke. Boysen G; Christensen H Stroke; 2001 Feb; 32(2):413-7. PubMed ID: 11157175 [TBL] [Abstract][Full Text] [Related]
37. Medical complications after stroke: a multicenter study. Langhorne P; Stott DJ; Robertson L; MacDonald J; Jones L; McAlpine C; Dick F; Taylor GS; Murray G Stroke; 2000 Jun; 31(6):1223-9. PubMed ID: 10835436 [TBL] [Abstract][Full Text] [Related]
38. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med; 1992 Jun; 20(6):864-74. PubMed ID: 1597042 [TBL] [Abstract][Full Text] [Related]